142 related articles for article (PubMed ID: 32529357)
1. Novel Assessment of Accessory Pathway Function in Patients with Wolff-Parkinson-White Syndrome.
Rigos LJ; Fishbein JS; Blaufox AD
Pediatr Cardiol; 2020 Aug; 41(6):1212-1219. PubMed ID: 32529357
[TBL] [Abstract][Full Text] [Related]
2. Difficulties with invasive risk stratification performed under anesthesia in pediatric Wolff-Parkinson-White Syndrome.
Shwayder MH; Escudero CA; Etheridge SP; Dechert BE; Law IH; Blaufox AD; Perry JC; Dubin AM; Sanatani S; Collins KK
Heart Rhythm; 2020 Feb; 17(2):282-286. PubMed ID: 31521806
[TBL] [Abstract][Full Text] [Related]
3. Loss of ventricular preexcitation during noninvasive testing does not exclude high-risk accessory pathways: A multicenter study of WPW in children.
Escudero CA; Ceresnak SR; Collins KK; Pass RH; Aziz PF; Blaufox AD; Ortega MC; Cannon BC; Cohen MI; Dechert BE; Dubin AM; Motonaga KS; Epstein MR; Erickson CC; Fishberger SB; Gates GJ; Capone CA; Nappo L; Kertesz NJ; Kim JJ; Valdes SO; Kubuš P; Law IH; Maldonado J; Moore JP; Perry JC; Sanatani S; Seslar SP; Shetty I; Zimmerman FJ; Skinner JR; Marcondes L; Stephenson EA; Asakai H; Tanel RE; Uzun O; Etheridge SP; Janson CM
Heart Rhythm; 2020 Oct; 17(10):1729-1737. PubMed ID: 32497761
[TBL] [Abstract][Full Text] [Related]
4. Assessing the utility of atrial fibrillation induction to risk stratify children with Wolff-Parkinson-White syndrome.
Apfel G; Choi NH; Silver ES; Liberman L
Cardiol Young; 2023 Jun; ():1-5. PubMed ID: 37309199
[TBL] [Abstract][Full Text] [Related]
5. Life-Threatening Event Risk in Children With Wolff-Parkinson-White Syndrome: A Multicenter International Study.
Etheridge SP; Escudero CA; Blaufox AD; Law IH; Dechert-Crooks BE; Stephenson EA; Dubin AM; Ceresnak SR; Motonaga KS; Skinner JR; Marcondes LD; Perry JC; Collins KK; Seslar SP; Cabrera M; Uzun O; Cannon BC; Aziz PF; Kubuš P; Tanel RE; Valdes SO; Sami S; Kertesz NJ; Maldonado J; Erickson C; Moore JP; Asakai H; Mill L; Abcede M; Spector ZZ; Menon S; Shwayder M; Bradley DJ; Cohen MI; Sanatani S
JACC Clin Electrophysiol; 2018 Apr; 4(4):433-444. PubMed ID: 30067481
[TBL] [Abstract][Full Text] [Related]
6. Intermittent versus Persistent Wolff-Parkinson-White Syndrome in Children: Electrophysiologic Properties and Clinical Outcomes.
Kiger ME; McCanta AC; Tong S; Schaffer M; Runciman M; Collins KK
Pacing Clin Electrophysiol; 2016 Jan; 39(1):14-20. PubMed ID: 26256551
[TBL] [Abstract][Full Text] [Related]
7. Pre-excited RR intervals during atrial fibrillation in the Wolff-Parkinson-White syndrome: influence of the atrioventricular node refractory period.
Fujimura O; Kuo CS; Smith BA
J Am Coll Cardiol; 1991 Dec; 18(7):1722-6. PubMed ID: 1960320
[TBL] [Abstract][Full Text] [Related]
8. Ventricular pre-excitation: symptomatic and asymptomatic children have the same potential risk of sudden cardiac death.
Di Mambro C; Russo MS; Righi D; Placidi S; Palmieri R; Silvetti MS; Gimigliano F; Prosperi M; Drago F
Europace; 2015 Apr; 17(4):617-21. PubMed ID: 25142741
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Nifekalant in Patients With Wolff-Parkinson-White Syndrome and Atrial Fibrillation: Electrophysiological and Clinical Findings.
Hu J; Yu J; Chen Q; Hu J; Huang Q; Xia Z; Xia Z; Ju Z; Yuan P; Fan S; Xiong Q; Zhu B; Huang L; You C; Bao H; Wu Y; Cheng X; Li J; Marian AJ; Hong K
J Am Heart Assoc; 2019 Jul; 8(13):e012511. PubMed ID: 31234695
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
Waspe LE; Brodman R; Kim SG; Fisher JD
Am Heart J; 1986 Dec; 112(6):1141-52. PubMed ID: 3788760
[TBL] [Abstract][Full Text] [Related]
11. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
[TBL] [Abstract][Full Text] [Related]
14. [Effect of heart rate on the refractory period of the accessory atrioventricular pathway in Wolff-Parkinson-White syndrome].
Fromer M; Gloor H; Kappenberger L
Schweiz Med Wochenschr; 1985 Nov; 115(44):1545-51. PubMed ID: 4081683
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of double ventricular response to a single atrial extrastimulus in patients with Wolff-Parkinson-White syndrome.
Matsuhisa M; Shimomura K; Ohe T; Kamakura S; Aihara N
Pacing Clin Electrophysiol; 1990 Apr; 13(4):443-52. PubMed ID: 1692128
[TBL] [Abstract][Full Text] [Related]
16. Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome.
Klein GJ; Yee R; Sharma AD
Circulation; 1984 Sep; 70(3):402-11. PubMed ID: 6744543
[TBL] [Abstract][Full Text] [Related]
17. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
Favale S; Minafra F; Massari V; Tritto M; Rizzon P
Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study.
Pappone C; Vicedomini G; Manguso F; Baldi M; Pappone A; Petretta A; Vitale R; Saviano M; Ciaccio C; Giannelli L; Calovic Z; Tavazzi L; Santinelli V
Circulation; 2012 Feb; 125(5):661-8. PubMed ID: 22215859
[TBL] [Abstract][Full Text] [Related]
19. [Asymptomatic pre-excitation. Identification of potential risk using transesophageal pacing].
Patruno N; Critelli G; Pulignano G; Urbani P; Villanti P; Reale A
Cardiologia; 1989 Sep; 34(9):777-81. PubMed ID: 2605586
[TBL] [Abstract][Full Text] [Related]
20. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
Swerdlow CD; Peterson J; Liem LB
Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
